Authorities in 27 European countries have now approved GRAZAX®, ALK-Abelló's tablet-based vaccine against grass pollen allergy. ALK-Abelló still expects to launch GRAZAX® on the first European markets by the end of 2006 and ahead of the 2007 pollen season.